China SXT Pharmaceuticals Inc (NASDAQ:SXTC) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 278,900 shares, a decline of 7.7% from the June 30th total of 302,200 shares. Based on an average daily trading volume, of 54,900 shares, the short-interest ratio is presently 5.1 days. Approximately 3.3% of the shares of the company are sold short.
SXTC traded up $0.05 during trading on Friday, hitting $2.61. 100 shares of the stock were exchanged, compared to its average volume of 19,284. China SXT Pharmaceuticals has a 1-year low of $1.97 and a 1-year high of $23.35. The stock has a fifty day moving average price of $2.85 and a two-hundred day moving average price of $4.64.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC bought a new position in China SXT Pharmaceuticals during the second quarter valued at about $72,000. Invesco Ltd. bought a new position in China SXT Pharmaceuticals during the second quarter valued at about $88,000. Finally, Spark Investment Management LLC bought a new position in China SXT Pharmaceuticals during the first quarter valued at about $94,000. 0.16% of the stock is currently owned by institutional investors.
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.
Featured Article: Total Return
Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.